An Industry Agenda for Advanced Therapies.

Scaling cell and gene therapies from promise to widespread impact requires a clear roadmap. This industry agenda outlines 11 priorities for biotech leaders to accelerate innovation, strengthen manufacturing, and expand patient access. Download the report to guide your strategy for scalable, accessible advanced therapies.